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Abstract 
The MAPs provide opportunities for developing a variety of safe and cost 
effective, prophylactic, and curative medicines for a number of maladies. It is 
estimated that the primary health care of over 80 per cent of the world’s 
population still depends on plant based traditional medicines (WHO, 2002). 
Growing consciousness about health and side effects of modern medicines has 
again set the stage for innovation and use of herbal medicines. Evidence shows 
that the total domestic potential for crude drugs and oil extracts in India is worth 
Rs 3 billion, of which the requirements of over-the-counter products. Realizing 
the vast untapped potentials of MAPs and impediments in their development. 
ATMA has follwoed a systematic approach while taking MAPs for pilot testing. It 
made assessement about the local conditions and requirements, and demand for 
MAPs; strengthened capacity by traing various stakeholders; played role in 
supporting individuals and institutions; developed relevant literature in local 
language; emphasized on group approach by organizing the growers; encouraged 
cultivation through the organized sector with linking the unorganized farmers; and 
evolved a pricing mechanism with buy back arrangement with partner industry 
under public-private partnership(PPP). The present study tries to outline some of 
the steps taken to promote MAPs in Bihar for better income to the farmers. 
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Introduction 
The history of cultivation and use of medicinal and aromatic plants (MAPs) in India is 
quite ancient. In one way or other, many of these plants have been an integral part of 
Indian health and livelihood systems. The MAPs provide opportunities for developing a 
variety of safe and cost effective, prophylactic, and curative medicines for a number of 
maladies. It is estimated that the primary health care of over 80 per cent of the world’s 
population still depends on plant based traditional medicines (WHO, 2002). Growing 
consciousness about health and side effects of modern medicines has again set the stage 
for innovation and use of herbal medicines. The global market for herbal products is 
continuously expanding and it is expected to touch the mark of US$ 5 trillion by the year 
2050, from the US$ 62 billion in 2004 (Purohit and Vyas, 2004). Despite being a major 
player, the share of India in global trade of MAPs is merely 0.5 per cent, whereas the 
countries, like China exports plants and raw drugs, therapeutics and other MAPs worth 
Rs 18,000 crores annually (Singh, 2005). India has one of the richest sources of many 
kinds of MAPs but it has achieved only a limited success in tapping the potentials of 
these plants because of low level of awareness among the farmers about the economic 
potential and returns (Purohit, 2004, Singh et al. 2007, Singh, 2008, Singh, 2009) from 
these plants.  
Economic Potentials of MAPs 
Estimates show that that the potential returns to farmer from cultivation of medicinal 
plants are quite high (Nautiyal, 1995; Rao and Saxena, 1994). The cultivation of certain 
high altitude Himalayan herbs could fetch products price anywhere between Rs. 7,150 to 
55,000 per hectare (Nautiyal, 1995). Although it is not clear that at which stage of the 
marketing chain these prices are paid but it is obvious that despite varying returns 
production of medicinal plants could raise the income of farmers to a great extent. Rao 
and Saxena (1994) reported an average annual income of Rs. 120,000 per hectaec 
through mixed cropping of high altitude medicinal herbs. Even the low altitude MAPs 
assume signicant economic importance and can be judiciously cultivated to bridge the 
current gap between demand (40 thousand tons) and supply (20 thousand tons) is 
estimated to be 40,000 to 200,000 tons, which is expected to rise to 152,000 to 400,000 
tons by 2005 (Planning Commission, 2000 & CRPA, 2001) to improve the income and 
status of the rural farm household. 
The demand for medicinal plants in India, to meet both domestic and export market, 
comprising of 162 species, is expected to increase at about 15 to 16% between 2002 and 
2005 (CRPA, 2001). Evidence shows that the total domestic potential for crude drugs and 
oil extracts in India is worth Rs 3 billion, of which the requirements of over-the-counter 
products. Including cosmetics and ethical and classical formulations, are of Rs 1.2 billion 
each; whereas traditional medicines of Vaidyas and hme reedial formulations acount for 
about Rs. 400 million and 200 million, respectively (Exim Bank, 1997).   Medicinal 
plants cultivation and management therefore, could become highly remunerative both in 
financial and economic terms for the small-scale growers. Not only the plants are in 
increasing demand by major herbal drug industries as an essential raw material of their 
drugs, but also its collection, production, processing, packaging and transportation 
requires high labor input, which can create job lead growth in job-starved state of Bihar. 
Collection from wild and selective harvesting in addition to primary processing is mostly 
done manually, and even at the secondary and tertiary levels, MAPs have substantial 
labour requirements. Moreover, not only do MAPs-based industries expand jobs, 
enhancing traditional uses through value added processing can increase cash earnings to 
the local people.    
Expanding world markets for MAPs are further opening up new vistas of opportunities. 
So far, Germany has been the largest market for MAPs but now the European market is 
growing rapidly at the rate of over 4% per annum for herbal remedies and even faster for 
herbal supplements. The size of European market for herbal supplements is estimated at 
over US$ 2.7 billion and for herbal remedies, a further US$ 0.9 billion. The US herbal 
market is, though nearing saturation but it is expected to peak at US$ 6-8 billion in the 
next few years. Thus the global demand for medicinal plants is expected to expand 
continuously, fuelled by the growth of sales of herbal supplements and remedies. Their 
basic uses in medicine will continue in the future, as a source of therapeutic agents, and 
as raw material base for the extraction of semi-synthetic chemical compound such as 
cosmetics, perfumes and food industries. All these pose a unique opportunity for India to 
penetrate deep into the world market to harness the untapped potentials of MAPs. 
Multi-faceted Importance of Medicinal and Aromatic Plants  
What are medicinal plants?  
A considerable number of definitions have been proposed for the term 'medicinal plant'. 
According to the World Health Organization, "a medicinal plant is any plant which, in 
one or more of its organs, contains substances that can be used for therapeutic purposes, 
or which are precursors for chemophar-maceutical semi synthesis".  
This definition allows for a distinction between the already known medicinal plants 
whose therapeutic properties or character as a precursor of certain molecules have been 
established scientifically, and other plants used in traditional medicines and regarded 
medicinal, but which have not yet been subjected to thorough scientific study. 
Plants for Health  
Today's healthcare systems rely largely on plant material. Much of the world's population 
depends on traditional medicine to meet daily health requirements, especially within 
developing countries. Use of plant-based remedies is also widespread in many 
industrialized countries and numerous pharmaceuticals are based on or derived from 
plant compounds. Similarly, cosmetics and other household products may contain plants 
of medicinal or therapeutic value.  
The pharmaceutical industry is both large and highly successful. Sales of plant derived 
drugs are expected to reach $30 billion worldwide in 2002. At present about 50% of the 
total plant-derived drug sales come from single entities, while the remaining 50% come 
from herbal remedies. Although the latter have greater volumes of consumption, the 
relatively low volumes of single entities, which are mostly prescription products, are 
more than compensated by their higher prices. Single entity plant drugs, which mostly 
treat serious medical ills, include atropine, digoxin, morphine, paclitaxel, pilocarpine, 
reserpine, scopolamine, topotecan and vincristine, among many others. Several of the 
compounds have outlived their usefulness in light of better alternatives, however, and are 
exhibiting decline in sales. On the other hand, as a consequence of new drug 
developments, single entities overall are projected to increase their market share of the 
combined total future dollar sales. 
Why Should the Bihar go the Herbal Way? 
Social Perspective 
Use of medicinal plants in primary health care and nutrition needs is traditional and 
imbedded in all cultures. No major problems of acceptability regarding familiarity with 
the usage of plant products, methods of cultivation of many commonly grown plants and 
technologies required for processing into items of common household uses and value. 
Med-plants have also been used to develop family-based health and livelihood oriented 
enterprises in rural areas. Medicinal and Aromatic Plants help in: 
a) Preserving the traditional medical knowledge,  
b) Provide easily adaptable enterprising opportunities for unemployed youth and rural 
poor who can learn the trade from their parents and peers and earn not only their 
livelihood but also contribute to the society.  
Protection of Traditional Knowledge 
The urgency and need to protect the fast disappearing medicinal plants-based traditional 
knowledge, which is still abundant in Bihar, cannot be overemphasized. If proper values 
can be added to the traditional medical knowledge-based health practices and 
subsistence-oriented HMAP applications, a large number of jobs can be created in the 
rural areas. Even at current level of conversion of traditional medicinal knowledge into 
economic opportunities, enterprise-based application can account for thousands of jobs in 
rural areas of Bihar. Thus, med-plants have high potential in creating jobs and pushing 
economic growth in resource-constrained areas suffering from limited educational 
opportunities, lack of infrastructure, and underdeveloped med-plants-based trade and 
commercial activities. The conversion of socio-cultural traditions and indigenous 
knowledge into livelihood means and economic opportunities also has the advantage of 
preserving the rapidly eroding cultural knowledge and practices which are increasingly 
threatened due to globalization and homogenization of people and communities.  
Environmental Perspective 
The growing apathy toward products made from chemical products becoming ethically 
unacceptable. This has created new markets for quality, certified and organic herbal 
products. Medicinal plants have the potential to fill these needs as they provide green 
health alternatives and a number of other eco-friendly products of domestic and industrial 
usage. Found as trees, shrubs, grasses and vines, these plant species abundantly growing 
in the plains of Bihar. Its entry into the world food and drug market as the environment 
friendly botanical products is looked upon as an emerging and new opportunity. The 
development of medicinal plants-based economic incentives is being increasingly applied 
to enlist greater participation of people in conservation of forest ecosystem. 
 
Potential of Equitable Commercialization  
The HMAP sub-sector has immense potential as the sustainable commercialization can 
benefit farmers and industry both by providing higher price and by opening up national 
and global markets for new products from the region. Private sectors stand to benefit by 
ensuring sustainable supply of quality raw materials to benefit their industry and trade if 
they can be facilitated to build partnerships with farmers. Many of the species are shade 
tolerant and others are climbers, trees, shrubs and herbs that can be grown in different 
configurations of crop geometry. 
Trade and Enterprise Development 
The demand for medicinal plants in India – to meet both domestic and export market - 
comprising 162 species, is expected to increase at about 15 to 16% between 2002 and 
2005 (CRPA, 2001). Medicinal plants cultivation and management therefore, can become 
highly remunerative both in financial and economic terms for the small-scale growers. 
The current gap between demand and supply is estimated to be 40,000 to 200,000 tons, 
which is expected to rise to 152,000 to 400,000 tons by 2005 (Planning Commission, 
2000 & CRPA, 2001). Not only the plants are in increasing demand by major herbal drug 
industries as an essential raw material of their drugs, but also its collection, production, 
processing, packaging and transportation requires high labor input, which can create 
employment in job-starved state of Bihar. Collection from wild and selective harvesting 
in addition to primary processing is mostly done manually, and even at the secondary and 
tertiary levels, med-plants have substantial labour requirements. Moreover, not only do 
HMAP-based industries expand jobs, enhancing traditional uses through value added 
processing can increase cash earnings to the local people.   
World Market Trends 
The European market for herbal supplements is estimated at over US$ 2.7 billion and for 
herbal remedies, a further US$ 0.9 billion. Germany is by far the largest market. The 
market is growing rapidly at over 4% per annum for herbal remedies and considerably 
faster for herbal supplements. The US herbal market is nearing saturation and is expected 
to peak at US$ 6-8 billion in the next few years. Demand for medicinal plants is expected 
to continue to expand rapidly, fuelled by the growth of sales of herbal supplements and 
remedies. Their basic uses in medicine will continue in the future,  as a source of  
therapeutic agents, and as raw material base for the extraction of semi-synthetic chemical 
compound such as cosmetics, perfumes and food industries.  
Domestication and Cultivation of HMAP 
Some of the practical applications integrating medicinal plants into traditional farming 
systems have taken an obligate relationship in backstopping upland agriculture. Other 
important opportunities and advantages of cultivating HMAPs include ease of their 
incorporation in the existing cropping systems due to availability of a large number of 
species and choice of plant types. Cultivation of carefully selected species as a mixed, 
inter or companion crop in agro and farm forestry conditions following a soil-improving 
crop rotation is highly feasible livelihood enhancing activities in Bihar. However, this 
will require an improved input and service delivery system including marketing, and post 
harvest technologies. Cultivation needs to be done on a business platform by a chain of 
small and micro-enterprise-based groups and individuals. In order to achieve an economy 
of scale and desired impact, it may need to be concentrated in selected pockets in an 
intensive manner as cluster of activities and micro-enterprises.  
Stakeholder's participation  
Local communities, especially weaker and marginalized groups or ethnic minorities need 
to be involved in planning, designing, development and implementation of the research 
activities and learning studies in the project. The NGOs and GOs should consult and 
work with community-based organizations and engage them into participatory process to 
involve collectors, producers and traders including ultimate users, women and 
disadvantaged groups in project implementation. In each of the selected villages or 
communities, stakeholder represented CBO, NGO or PRI should implement and/or 
supervise the execution of projects. Their involvement from the very beginning of the 
project development process is expected to enhance people’s participation in the project 
and provide benefit to a wide range of users. 
 
 
Marketing Perspective 
In order to understand the complex market and marketing related issues, market-
related information, scooping of problems & opportunities, successful case studies 
with `good practice’ tag need to be surveyed and studied to develop a marketable 
product portfolio. The tool proposed is value-chain or Production-to-Consumption & 
Marketing (PC&M) model. The outcome of these studies can be useful to plan 
equitable commercialisation, identify potential small & micro enterprises, and assess 
available raw material resources and product mix. 
Steps taken 
Taking cognizance of such enormous and grossely untapped potentials of MAPs, the 
Government of India has accorded high priority to the R&D and cultivation of MAPs in 
the country. A number of techniques have been developed to increase the quality and 
yield of many of the cultivated species. It is estimated that Indian public sector research 
institutions have developed standardized practices for the propagation and agronomy of a 
total of about 40 species.  
Much of the research progress to date has resulted from the decision of the Indian 
Council for Agricultural Research (ICAR) to establish an All-India Coordinated Research 
Project on Medicinal and Aromatic Plants (AICRPMAP), in 1972, under the auspices of 
the National Bureau of Plant Genetic Resources (NBPGR). Efforts have mainly focused 
on the development of agro-technology techniques, including propagation methods for 
medicinal and aromatic plants. Aromatic plants have however tended to receive more 
attention, perhaps because their market values are in general more widely known. ICAR 
works through a network of research stations, including the National Research Centre for 
Medicinal and Aromatic Plants located in Anand, Gujarat, which specializes in 
domestication, and has created structural links between the NBPGR and its Plant 
Breeding Division in order to develop improved varieties of some of the medicinal plant 
species used in allopathic preparations. 
The Council for Scientific and Industrial Research (CSIR), has also played a significant 
role with regard to cultivation of medicinal plants, by establishing the Central Institute of 
Medicinal and Aromatic Plants, in Lucknow (CIMAP). CIMAP is now an eminent 
institution in India focusing on agro-technology as well as basic studies; improvement 
and enhancement of the resource base, and chemistry and related research regarding 
product development from plants. 
Apart from these, the Government of India launched a scheme for the development of 
MAPs during the 8th Five Year Plan (1992-97). The scheme attempted to include 
production quality planting materials, establihment of herbal gardens and regional 
analytical laboratories with the help of 16 state agricultural universities, state horticulture 
and agriculture departments, regional research laboratories and the International Crop 
Research Institute for the Semi-Arid Tropics (ICRISAT). There are other actors also who 
are playing important role in the development and production of MAPs. For instance, 
Ministry of Health & Family Welfare (Department of ISM&H) and a number of private 
agencies/ companies are also encouraging development of agrotechnique for important 
species with the help of Govt/semi-government organisations having expertise and 
infrastructure for this work.  
In addition, the centre and state (governments) have made provisions for adequate 
financial supports in the forms of subsidies and loans to the growers of MAPs throgh 
various agencies like National Medicinal Plant Board (NMPB), National Bank for 
Agricultural and Rural development (NABARD), Agricultural and Processed Food 
Products Export Development Authority (APEDA), National Horticultural Board (NHB), 
Agri-Export Zone (AEZ), etc. The NMPB supports several promotional as well as 
commercial programmes and provides cent per cent financial assistance to promote 
MAPs in the country. The Integrated Development of Medicinal and Aromatoc Plants, 
Ministry of Agriculture is also a commendable step that supports production to 
processing as well as training of the farmers with limited financial assistance.  
Current status  
Table 1 shows details of area, production and yield of various aromatic plants in 2009-10 
in Bihar. It is obvious that cultivation of medicinal plants is quite limited and only 2410 
ha of land was under cultivation of these plants. Among different commercially growing 
species of aromatic plants, mentha and lemon grass have emerged as the major players 
and shared 95 per cent in total area and production of aromatic plants in the state.  
Table 1. Details of aromatic crops being grown in Bihar (2009-10) 
MAPs Area 
(ha.) 
Total oil 
production 
(tons) 
Oil yield 
(kg./Ha.) 
Lemon grass 185 25.90 140 
Java citronella 38 4.75 125 
Mentha  2100 252.00 120 
Palma rosa 20 2.00 100 
Tulsi (basil) 32 3.20 100 
Jama rosa/CN-5 35 5.25 155 
Source: Author’s calculation 
As far as the status of medicinal plants in Bihar is concerned (table 2), it is still 
negligible. Merely 380 tons of medicinal plant produces are being produced over 95 ha of 
land. Evidence indicates that commercial cultivation of some of the species of MAPs are 
picking up in the state but still a lot of efforts are required to observe the real impacts of 
their cultivation (Singh, 2007). Impetus in terms of planning, funding, production, 
processing, and strong market linkage is essential to harness the potentials of commercial 
production of MAPs. 
Table 2.  Details of medicinal crops being grown in Bihar(2009-10) 
MAPs Area 
(ha.) 
production 
(ton) 
yield 
(kg./Ha.) 
Safed musli (Chlorophytum 
borivillinum) 
16 24.0 1500 
Kalmegh (Andrographis 
penniculata) 
15 45.0 3000 
Sarpgandha (Rauwolfia serpentina) 12 19.2 1600 
Shatawar (Asparagus racemosus) 17 127.5 7500 
Buch (Acorous calamus) 6 19.2 3200 
Jatropha (Jatropha curcas) 29 145.0 5000 
Source: Author’s calculation 
 
Efforts to popularize Medicinal and Aromatic Plants in Bihar 
Realizing the vast untapped potentials of MAPs and impediments in their development, 
Bihar Agricultural Management and Training Institute (BAMETI) has made remarkable 
efforts to promote MAPs in the state under ATMA, Patna.  ATMA has follwoed a 
systematic approach while taking MAPs for pilot testing. It made assessement about the 
local conditions and requirements, and demand for MAPs; strengthened capacity by 
traing various stakeholders; played role in supporting individuals and institutions; 
developed relevant literature in local language; emphasized on group approach by 
organizing the growers; encouraged cultivation through the organized sector with linking 
the unorganized farmers; and evolved a pricing mechanism with buy back arrangement 
with partner industry under public-private partnership(PPP).  
 
2a. Identify markets for 
high-value crops/products 
2b. BTTs organize FIGs & 
assess interest in HVC/P 
Step 1. ATMA organizes PRA, then ATMA Mgt. Cte. develops SREP for the district  
4. Arrange for planting material and other inputs needed 
to produce high-value crops or products 
5. FIG members produce crop or product to specification; BTT and/or buyer’s 
staff members supervise production and provide technical support as needed 
2c. Consult with research; 
KVK tests new technologies 
3b. ATMA facilitates contracts 
between FIGs and buyers 
 
3c. Arrange for KVK to train 
FIG members 
6. FIG members harvest, handle, process, and/or market the product to the 
buyer’s specification or to ensure the marketability of the crop or product 
3a. FIG leaders oriented 
through exposure visits  
Source: Singh and Swanson, 2006 and Singh, Swanson and Singh, 2006, p. 212) 
Figure 1. Steps taken by ATMA, Patna to Develop Supply Chains of MAPs in Bihar 
Economics of MAPs vis-à-vis other field crops 
The comparative economics of MAPs and a few major field crops reveals that returns 
from MAPs are comparable with any of the field crops. The returns from medicinal 
plants like safedi musali, sarpgandha, satawari, are fairly high. Similarly, returns from 
aromatic plants like lemon grass, rosa species, etc. are yield better returns and also their 
cost of cultivations are lower in comparasion to many of the field crops. The irony is that 
over 80 percent of the Bihar population is smallholder (<2ha of land size) and therefore, 
they generate very small marketable surplus. Such a small scale production and tiny 
marketable surplus fail to attract markets.  
Table 3. Economics of some MAPs Cultivation in Bihar 
Crops Cost of 
cultivation 
(Rs/ha) 
Gross 
income 
(Rs/ha) 
Net income 
Rs/ha/ year 
Lemon grass 22500 42000 19500 
Java citronella 19500 33750 14250 
Mentha  20500 36000 15500 
Palma rosa 22500 40500 18000 
Tulsi (basil) 11500 20000 8500 
Jama rosa/CN-5 25000 50375 25375 
Safed musli (Chlorophytum borivillinum) 65000 102000 37000 
Kalmegh (Andrographis penniculata) 58000 65000 7000 
Sarpgandha (Rauwolfia serpentina) 30000 64000 34000 
Shatawar(Asparagus racemosus) 25000 50000 25000 
Buch (Acorous calamus) 25000 40000 15000 
Jatropha (Jatropha curcas) 17000 30000 13000 
Paddy-wheat 42947 58853 15906 
Sugarcane 48343 84323 35980 
Source: Author’s calculations 
The Efforts so far by ATMA, Patna: 
The efforts by ATMA, Patna to promote the MAP sector can be summarized in the 
following manner: 
1. Assessment of Local Conditions and Requirements: 
2. Assessing the Demand for Medicinal and Aromatic crops 
3. Training and Capacity Building by ATMA, Patna 
4. Role of Supporting Individuals and Institutions 
5. Development of Relevant Literature in Local language 
6. Emphasis on Group Approach 
7. Organizing the Growers 
8. Cultivation through the Organized Sector and linking the unorganized farmers 
9. Pricing Mechanism and Buy Back Arrangement with partner industry 
Medicinal Plants Suitable for Selective Commercialization in Bihar 
• Sadabahar (Catharanthus roseus) 
• Gurmar (Gymnema sylvestris) 
• Sarpgandha (Rauvolfia serpentine) 
• Kalmegh (Andrographis paniculata) 
• Kalihari ( Gloriosa superba) 
• Brahmi (Centella asiatica) 
• Buch (Acorus calamus) 
• Pippli (Piper longum) 
• Shatawari (Asparagus racemosum) 
• Chitrak (Plumbago zeylanica)  
Aromatic Plants Suitable for Selective Commercialization in Bihar 
• Lemon grass (Cymbopogon fleuosus) 
• Palma rosa (Cymbopogon martinii) 
• Java citronella (Cymbopogon  winterianus) 
• Mentha (Mentha arvensis) 
• Tulsi (Ocimum basilicum) 
• Vetiver (Vetiveria zizanioides) 
Bio-Partnership to link Rural Communities with Industry  
Links established with growers, traders, processors and consumers at different levels in a 
value-chain or production-to-consumption system framework.  Equitable Bio-partnership 
arrangements between processing and marketing; health-care companies and community-
based organizations developed to ensure dependable markets for the producers and 
quality supply for the industry. Industries have shown interest in direct collaboration with 
producer groups/associations and many are committed to a fair and ethical 
commercialisation.  
Response from the Farmers  
Presently with support of ATMA, Patna about 500 acres of land has been brought under 
the cultivation of MAPs in Bihar. The number of farmers and area under these crops is 
likely to increase in future as a large number of farmers have expressed an interest in 
medicinal plant cultivation. In Bihar, there is already a Growers Association promoting 
cultivation of medicinal plants for enhancing livelihoods promoted by ATMA, Patna. 
Marketing Strategies Adopted  
Given the scarcity of the medicinal plants such as Vinca rosa (Sadabahar or Catharanthus 
roseus), Sarpgandha (Rauvolfia serpentina), Buch (Acorus calamus), Brahmi (Centella 
asiatica), Shatawar  (Asparagus racemosum), Pippli (Piper longum), Gurmar (Gymnema 
sylvestris), Patharchoor ( Coleus froscolli), etc sourced from farms, drug companies have 
assured the full-purchase price of these herbs. ATMA, Patna negotiated several formal 
bio-partnerships between certified farmers and Ayurvedic pharmaceutical companies, 
like Baidyanath Ayurved Bhawan, Patna; Ayurved Shri Herbals Ltd, Ahmedabad, 
Fragrance Herbs, Patna etc. The arrangement ensures that farmers with a guaranteed 
market and a fixed fair price for their harvest, in exchange for exclusive rights to the 
produce as the sole buyer.  
Future Strategies  
Though commercial cultivation of some of the species of MAPs are picking up in the 
state but still a lot of efforts are required to observe the real impacts of their cultivation 
(Singh, et al. 2007, Singh, 2009). Impetus in terms of planning, funding, production, 
processing, and strong market linkage is essential to harness the potentials of commercial 
production of MAPs. Formal bio-partnerships between certified farmers and Ayurvedic 
pharmaceutical companies, like Baidyanath Ayurved Bhawan, Patna; Ayurved Shri 
Herbals Ltd, Ahmedabad, Fragrance Herbs, Patna  needs to be explored. The arrangement 
should ensure farmers with a guaranteed market and a fixed fair price for their harvest, in 
exchange for exclusive rights to the produce as the sole buyer.  
The other agencies like departments of Forest, Agriculture, Horticulture, Health and 
Family Welfare can come together to offer technical, market related and other input 
supply services to the various stake holders so that sector as a whole can grow and 
dependence on outside sources for primary health care is minimized. Use of farmer 
Interest Groups for dissemination of technology and market information can also be 
explored in the state. 
References 
CRPA, 2000. Demand Study for Selected Medicinal Plants: Volume I & II. Center for 
Research, Planning and Action (CRPA) for Ministry of Health & Family Welfare, 
GOI, Department of ISM&H & WHO, New Delhi, India.  
Export Import Bank of India. 1997. Indian Medicinal Plants: A Sector Study . Export 
Import Bank of India, Occasional Paper No. 54. 
Kanel, K.R., 2000. Sustainable Management of Medicinal and Aromatic Plants in Nepal: 
A strategy. A Study Commissioned by IDRC/SARO, Medicinal and Aromatic 
Plants Program in Asia (HMAPPA); New Delhi, India 
Karki, M.B., 2000. Commercialization of Natural Resources for Sustainable Livelihoods: 
the case of forest products; Paper presented at the International Conference on 
Growth, Poverty Alleviation and Sustainable Management in the Mountain Areas 
of South Asia organized by German Foundation for International Development 
(DSE) and International Centre for Integrated Mountain Development (ICIMOD); 
January 31- February 4, 2000; Kathmandu, Nepal; 
Karki, M.B. 2002. Organic Conversion & Certification: A Strategy for Improved Value-
Addition and Marketing of Medicinal Plants Products in the Himalayas; Paper 
presented at the Regional Workshop at Wise Practices and Experimental Learning 
in the Conservation and Management of Himalayan Medicinal Plant; December 
15-20, 2002; Kathmandu, Nepal 
Planning Commission, 2000. Report of the Taskforce on Medicinal Plants in India. 
Planning Commission, Government of India, Yojana Bhawan, New Delhi, India 
Regmi S. & Bista, S. 2002.Best Practices in Collection and Cultivation of Medicinal 
Plants for Sustainable Livleihoods in Himalayan Communities; Paper presented at 
the Regional Workshop at Wise Practices and Experimental Learning in the 
Conservation and Management of Himalayan Medicinal Plant; December 15-20, 
2002; Kathmandu. CECI- Nepal. 
Nautiyal MC. 1995 Agro-techniques of some high altitude medicinal herbs. In: Dehra 
Dun, India: Bishen Singh Mahendra Pal Singh 53-64. ISBN 8121101220. 
Planning Commission, 2000. Report of the Taskforce on Medicinal Plants in India. 
Planning Commission, Government of India, Yojana Bhawan, New Delhi, India 
Purohit, S.S. and S.P, Vyas. 2004. Marketing of medicinal and aromatic plants in 
Rajasthan, National Consultative  Workshop on Medicinal and Artomatic Plants, 
held at GBPUAT, Pantnagar. 
Rao, K. S.; Saxena, K. G.  1994. Sustainable development and rehabilitation of degraded 
village lands in Himalaya. HIMAVIKAS Publication - G.B. Pant Institute of 
Himalayan Environment and Development (India), No. 8pp. P.301  
Singh, H. P. 2005. Promotion of medicinal and aromatic plant sector in Uttarakhand. 
Need of hour. National Consultative  Workshop on Medicinal and Artomatic 
Plants, held at GBPUAT, Pantnagar.  
Singh, K.M. 2012. Commercializing Agriculture in Eastern India: Some Pertinent Issues 
http://dx.doi.org/10.2139/ssrn.2048141 
Singh, K.M. 2013. Use of Chemical Fertilizer for Lemon Grass Cultivation in Bihar 
            http://dx.doi.org/10.2139/ssrn.2168651 
Singh, K. M., Umesh Singh, and Pushpa Singh.  2007. A Study on Role of ATMA, Patna 
in Development of Supply Chain for Medicinal Plants in Patna District, Bihar 
(India) 
Singh, K.M. and A.K.Jha. 2008.Medicinal and Aromatic Plants Cultivation in Bihar, 
India: Economic Potential and Condition for Adoption. 
http://dx.doi.org/10.2139/ssrn.2213308  
Singh,.K.M. 2009. Scope of Medicinal and Aromatic Plants Farming in Eastern India. 
http://dx.doi.org/10.2139/ssrn.2019789   
Singh, K.M., and B.E. Swanson. 2006. “Developing market-driven extension system in 
India.” Proceedings of the 22nd Annual Meeting of the Association for 
International Agricultural and Extension Education, Clearwater Beach, FL, 14–
17 May, 2006. http://dx.doi.org/10.2139/ssrn.2048175 
Singh, K. M., B. E. Swanson, and J. P. Singh. "Development of supply chains for 
medicinal plants: a case study involving the production of vinca rosa by small 
farmers in the Patna District of Bihar India." Workshop on Building New 
Partnerships in the Global Food Chain, Chicago. 2005. 
http://dx.doi.org/10.2139/ssrn.2030701 
Singh, K.M. and Prasad, K. 2005. Potential and Possibilities of medicinal and Aromatic 
Plants. In Proceedings of National Workshop on Exploring Opportunities for 
Cultivation of Important Medicinal Plants of Palamau (Jharkhand). Society for 
Environmental and Social Awareness (SESA). pp.36-42 
World Health Organization (WHO). 2002. Traditional Medicine Strategy 2002-2005. 
Website: www.who.int/medicines/library/trm/trm_start_eng.pdf. 
